Discovery of new targeting agents against GAPDH receptor for antituberculosis drug delivery.

Muhammad Amirul Asyraf NohSiti Sarah Fazalul RahimanHabibah A WahabAmirah Mohd Gazzali

Published in: Journal of basic and clinical physiology and pharmacology (2021)

Folic acid and the two derivatives F7 and F8 have huge potentials to be developed as targeting agents against the GAPDH receptor. Further study is currently on-going to evaluate the effectiveness of these molecules in vitro.

Keyphrases

drug delivery
cancer therapy
randomized controlled trial
systematic review
binding protein
drug release